Note: NNRTIs, Non-nucleoside reverse transcriptase inhibitors; NVP, Nevirapine; EFV, Efavirenz; DLV, Delavirdine; NRTIs Nucleoside reverse transcriptase inhibitors; FTC, Emtricitabine; 3TC, Lamivudine; ABC, Abacavir; D4T, Stavudine; DDI, Didanosine; AZT, Azidothymidine; TDF, Tenofovir; PIs, Protease inhibitors; NFV, Nelfinavir; ATV, Atazanavir; TPV, Tipranavir; IDV, Indinavir; LPV, Lopinavir; SQV, Saquinavir; FPV, Fosamprenavir; APV, Amprenavir; RTV, Ritonavir; DRV, Darunavir.

Figure 2: HIV drug resistance for each drug among 708 patients with plasma HIV-1 RNA concentrations = 1000 copies/ml and with drug resistance.

Goto home»